ZBH · NYSE
Zimmer Biomet Holdings (ZBH) Stock Price & Fundamentals
Zimmer Biomet Holdings (ZBH) closed at $889.87 on Oct 9, 2026, up 1.24% from the previous close of $878.98.
Share price, past year
1Y +25.82%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $889.87 |
| Sep 30, 2026 | $863.05 |
| Aug 31, 2026 | $816.95 |
| Jul 31, 2026 | $818.10 |
| Jun 30, 2026 | $836.28 |
| May 29, 2026 | $787.15 |
| Apr 30, 2026 | $849.90 |
| Mar 31, 2026 | $845.41 |
| Feb 27, 2026 | $811.77 |
| Jan 30, 2026 | $813.06 |
| Dec 31, 2025 | $771.60 |
| Nov 28, 2025 | $753.10 |
| Oct 31, 2025 | $734.67 |
Key statistics
- Market cap
- $169.73B
- P/E (TTM)
- 216.0
- EPS (TTM)
- $4.12
- Revenue (TTM)
- $8.51B
- Net income (TTM)
- $806.70M
- Shares outstanding
- 190.7M
- Dividend yield
- 0.11%
- 52-week range
- $704.36 – $889.87
Zimmer Biomet Holdings's market cap is $169.73B, based on a share price of $889.87 and 190.7M shares outstanding as of Jul 30, 2026.
Financials
Zimmer Biomet Holdings reported revenue of $8.23B for fiscal 2025, up 7.20% from fiscal 2024.
Zimmer Biomet Holdings earned net income of $705.10M in fiscal 2025, a net margin of 8.6%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $8.23B | +7.2% | $705.10M | 8.6% | $3.55 | $1.47B |
| FY2024ended Dec 31, 2024 | $7.68B | +3.9% | $903.80M | 11.8% | $4.43 | $1.30B |
| FY2023ended Dec 31, 2023 | $7.39B | +6.6% | $1.02B | 13.9% | $4.88 | $1.29B |
| FY2022ended Dec 31, 2022 | $6.94B | +1.7% | $231.40M | 3.3% | $1.10 | — |
| FY2021ended Dec 31, 2021 | $6.83B | +11.4% | $401.60M | 5.9% | $1.91 | $1.36B |
| FY2020ended Dec 31, 2020 | $6.13B | −23.2% | −$138.90M | −2.3% | −$0.67 | $1.09B |
| FY2019ended Dec 31, 2019 | $7.98B | +0.6% | $1.13B | 14.2% | $5.47 | $1.38B |
| FY2018ended Dec 31, 2018 | $7.93B | +1.7% | −$379.20M | −4.8% | −$1.86 | $1.58B |
| FY2017ended Dec 31, 2017 | $7.80B | +1.8% | $1.81B | 23.2% | $8.90 | $1.43B |
| FY2016ended Dec 31, 2016 | $7.67B | — | $305.90M | 4.0% | $1.51 | $1.45B |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $2.18B | $198.30M | $1.03 |
| Q1 FY2026ended Mar 31, 2026 | $2.09B | $238.10M | $1.22 |
| Q4 FY2025ended Dec 31, 2025 | $2.24B | $139.40M | $0.71 |
| Q3 FY2025ended Sep 30, 2025 | $2.00B | $230.90M | $1.16 |
| Q2 FY2025ended Jun 30, 2025 | $2.08B | $152.80M | $0.77 |
| Q1 FY2025ended Mar 31, 2025 | $1.91B | $182.00M | $0.91 |
| Q4 FY2024ended Dec 31, 2024 | $2.02B | $239.50M | $1.18 |
| Q3 FY2024ended Sep 30, 2024 | $1.82B | $249.10M | $1.23 |
Company profile
- Name
- Zimmer Biomet Holdings, Inc.
- Ticker
- ZBH
- Exchange
- NYSE
- Industry (SEC SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- 345 East Main Street, Warsaw, IN 46580
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001136869
Recent SEC filings
- Sep 8, 2026
- Aug 5, 2026
- Aug 5, 2026
- Aug 5, 2026
- Jun 29, 2026
- May 27, 2026
- May 12, 2026
- May 1, 2026
Frequently asked questions
What is Zimmer Biomet Holdings's stock price?
Zimmer Biomet Holdings (ZBH) closed at $889.87 on Oct 9, 2026, up 1.24% from the previous close of $878.98.
What is Zimmer Biomet Holdings's market cap?
Zimmer Biomet Holdings's market cap is $169.73B, based on a share price of $889.87 and 190.7M shares outstanding as of Jul 30, 2026.
How much revenue does Zimmer Biomet Holdings make?
Zimmer Biomet Holdings reported revenue of $8.23B for fiscal 2025, up 7.20% from fiscal 2024.
What is ZBH's P/E ratio?
Zimmer Biomet Holdings's price-to-earnings ratio is 216.0, based on trailing twelve-month diluted EPS of $4.12.
Does Zimmer Biomet Holdings pay a dividend?
Yes. Zimmer Biomet Holdings declared $0.96 per share in dividends over the last four quarters, a yield of 0.11%.
Sources and methodology
Fundamentals come from Zimmer Biomet Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures